Host/Editor: Dr. Robert Harmon, Chief Medical Resident at UCONN. With this episode we will wrap up the ambulatory series for the 2022-2023 academic year. Huge shoutout to Alla Turshudzhyan for all of the work that she put into the podcast over the last year. We are very excited for her as she moves on to the next phase of her career! For my inaugural episode, we will be discussing medical abortion. There are two medications that are approved by the FDA for medical abortion; mifepristone and misoprostol. Most commonly these are administered as part of a combined regimen in which misoprostol is administered 24-28 hours after mifepristone. It is important to know that patients can resume any form of contraception after medical abortion and fertility is not effected by past medical abortion! Patients are eligible for medical abortion up until 70 days of gestation, which is determined by the patient's first day of their last menstrual cycle. Ultrasound is not required unless gestational age is not able to be determined, the patient is at high risk for ectopic pregnancy or has clinical signs of an ectopic pregnancy. I look forward to putting out some exciting content this year! Thank you for listening.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related